The Immune Symphony Conducted by the Microbiome: A Review

Abstract

The human gut microbiota, comprising trillions of bacteria, viruses, fungi, and other microorganisms, forms a highly dynamic ecosystem essential for host health. It plays a pivotal role in the development, regulation, and functioning of the immune system. Microbial metabolites, including short-chain fatty acids (SCFAs), bile salts, and tryptophan derivatives, influence mucosal defense, immune cell maturation, and inflammation control. Current evidence from animal models, particularly germ-free (GF) mice, and human studies highlights the significance of gut microbial exposure in immune development. Factors such as age, diet, antibiotics, and geography shape microbial composition, which in turn regulates immune cell signaling pathways and activates pattern recognition receptors (PRRs). Findings demonstrate that a balanced and diverse microbiota is critical for immune homeostasis, while dysbiosis impairs immune regulation. Both innate immune cells (dendritic cells, macrophages) and adaptive immune cells (T and B lymphocytes) are influenced by gut microbes through molecular and metabolic interactions. GF mice consistently show immature immune systems, emphasizing the indispensable role of microbiota in immune maturation. The gut microbiota is fundamental in maintaining immune balance and systemic health. Disruptions in microbial diversity contribute to immune-related diseases, while therapeutic interventions such as probiotics, prebiotics, and fecal microbiota transplantation show promise in restoring microbial equilibrium. Continued research into host–microbiota interactions offers innovative opportunities for microbiome-based therapies targeting immune-mediated disorders.